This week we give special recognition and honor to our military veterans on Veteran’s Day. It’s an opportunity to say thank you for your service to the veterans who are… Read more
Posted by Wayne Embree in #Startup Buzz
The story of Celenex is special. It starts with two passionate, devoted parents whose daughters were born with Batten disease (also known as Neuronal ceroid lipofuscinosis – NCL), one of… Read more
Posted by Wayne Embree in #Startup Buzz
Posted by Wayne Embree in Getting Funding
Posted by Wayne Embree in #Startup Buzz
In medicine, pathologists are known as the doctors’ doctors. Whether the task at hand is to diagnose an individual patient or to study the influence of a particular cell on… Read more
Posted by Wayne Embree in #Startup Buzz
MYO-101 Phase 1/2a systemic gene therapy trial for LGMD2E to begin in early 2018 New Albany, OH, 13 December 2017 – Myonexus Therapeutics, Inc. (Myonexus), a clinical-stage biotechnology company developing… Read more
Posted by Wayne Embree in #Startup Buzz
Myonexus Therapeutics is a clinical stage gene therapy company developing first-ever gene treatments for multiple types of limb-girdle muscular dystrophy (LGMD), a group of progressive, debilitating musculoskeletal genetic diseases that… Read more
Posted by Wayne Embree in #Startup Buzz
The Columbus-based startup, Noxsano is a reminder that not all medical technology comes from state-of-the-art laboratories in large research institutions. Like Microsoft and Hewlett Packard, the technology at the core… Read more
Posted by Wayne Embree in #Startup Buzz
Nanofiber Solutions™, an Ohio-based regenerative medicine company, is developing a new class of medical implants for soft tissue and organ repair and replacement. The firm provides absorbable, three-dimensional (3-D) nanofiber… Read more
Posted by Wayne Embree in #Startup Buzz
